About Us: Company at a Glance


Our Mission


To provide our customers with the finest, high-quality
biomarker​ service.


Our Vision


To predict the response to the high value medicines of tomorrow.

Our Values


Founded in Kassel, Germany in 2005 by Dr. Thomas Henkel, Prof. Josef Rüschoff and Prof. Reinhard Büttner.


120 in three divisions.


+16 senior clinical pathologists on site in Kassel plus consultant pathologists form Kassel, Göttingen, Essen.
+20 consulting expert pathologist from Germany, UK, USA, Spain, Brazil for Biomarker Training and Standardization


Pathologie Nordhessen, Kassel,  University of Cologne, Cologne University of Göttingen, Göttingen, University of Essen, University of Frankfurt all Germany.
UPenn Medical School, Philadelphia, USA.
Collaborations with more than 40 industry leading pharmaceutical, biotech and diagnostic companies in Europe and United States.​

Companion Diagnostics

·The first co-development of companion diagnostics for Roche COBAS and B-Raf together with Genentech/Roche drug Zelboraf in a prospective clinical trial.
·HercepTest™ for Herceptin™ for Gastric Cancer in a prospective clinical trial.

Quality Assurance

Audited annually since 2005 by FDA, Pharma PDQA and Biotech QA.
CAP accreditation since 2013 and CLIA accreditation since 2014.

Central & Reference Laboratory

For Europe, USA, Asia, Latin America and the Middle East.


High impact publications of supported trials in The Lancet, New England Journal of Medicine, Journal of Clinical Oncology etc.


Prof. Dr. med. Josef Rüschoff: International Herceptin Pathology Advisory Board.
Prof. Dr. med. Reinhard Büttner: Member of the German Academy for Sciences.

Turn-around Time

As low as 24 hours for clinical tissue biomarker analysis

Global Clinical Trials

Reference laboratory for global clinical trials. Analysis of 250+ biomarkers in more than 125,000 patients in 400 clinical trials serving more than 1.000 clinical centers wordwide.